Circulogene Theranostics, Inc.
Circulogene Theranostics, Inc., headquartered in the United States, is a pioneering company in the field of precision medicine and liquid biopsy technology. Founded in 2016, Circulogene focuses on advancing cancer diagnostics and monitoring through its innovative blood-based tests, which provide critical insights into tumour dynamics and treatment responses. With a commitment to enhancing patient outcomes, the company offers unique services that leverage advanced genomic analysis to detect circulating tumour DNA (ctDNA). This approach not only aids in early cancer detection but also facilitates personalised treatment strategies. Circulogene has established a strong market position, recognised for its contributions to the oncology landscape, and continues to drive advancements in theranostics, making significant strides in the fight against cancer.
DitchCarbon Score
How does Circulogene Theranostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Circulogene Theranostics, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Circulogene Theranostics, Inc.'s reported carbon emissions
Circulogene Theranostics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Circulogene may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within the biotechnology sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Circulogene Theranostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
